glp-1 microdosing What should you know before starting a GLP-1? GLP-1 Microdosing: A Medical Perspective

Apr 2019;7(4):1426-1437

10.1056/NEJMoa2301972 36 JastreboffA

On the plus side, they typically have very minimal and mild side effects compared to prescription medications

Patients with elevated baseline inflammatory markers (CRP, IL-6) or copper metabolism disorders may face higher risk of adverse reactions

Targeting both simultaneously has the potential to produce weight loss outcomes that neither drug could achieve alone without simply doubling the side effects

Off-label use simply means a provider is using a substance for a purpose other than its original intention, based on professional judgment and clinical evidence